ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Zydus Lifesciences scheduled a board meeting for August 11, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Zydus Lifesciences will hold a board meeting on May 19, 2026, to consider a share buyback proposal. The trading window remains closed until May 21.
Zydus Lifesciences scheduled a board meeting on May 19, 2026, to approve audited FY26 results and recommend a final dividend. Trading window remains closed until May 21.